VREOF
Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
General Counsel
Vireo Growth Inc. (VREOF)Equibles does not estimate personal net worth.
Get an email with a short summary when Vireo Growth Inc. publishes a filing, an earnings call transcript or a press release.
Get VREOF alertsSean M. Apfelbaum is recorded as General Counsel at Vireo Growth Inc. (VREOF). The newest filing on record that lists Sean M. Apfelbaum as General Counsel at Vireo Growth Inc. (VREOF) is dated April 16, 2026. The proxy statement of Vireo Growth Inc. reports total compensation of $574,633 for Sean M. Apfelbaum in fiscal 2025, including a base salary of $145,833. Vireo Growth Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Vireo Growth Inc. includes Amber H. Shimpa (CEO), Amber Shimpa (CEO), John Mazarakis (CEO, Chairman and Board Member) and 7 others.
Start not stated–present
Last confirmed April 16, 2026
VREOF
Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vireo Growth Inc. (VREOF) | General Counsel | $145,833 | $574,633 |
No call appearances or filed executive changes recorded yet.